ES425936A1 - Procedimiento para preparar compuestos antihistaminicos. - Google Patents

Procedimiento para preparar compuestos antihistaminicos.

Info

Publication number
ES425936A1
ES425936A1 ES74425936A ES425936A ES425936A1 ES 425936 A1 ES425936 A1 ES 425936A1 ES 74425936 A ES74425936 A ES 74425936A ES 425936 A ES425936 A ES 425936A ES 425936 A1 ES425936 A1 ES 425936A1
Authority
ES
Spain
Prior art keywords
prepare
procedure
antihistamine compounds
compounds
antihistamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES74425936A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES425936A1 publication Critical patent/ES425936A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES74425936A 1973-05-03 1974-05-03 Procedimiento para preparar compuestos antihistaminicos. Expired ES425936A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2106373A GB1419994A (en) 1973-05-03 1973-05-03 Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB3555173 1973-07-26

Publications (1)

Publication Number Publication Date
ES425936A1 true ES425936A1 (es) 1976-09-16

Family

ID=26255089

Family Applications (1)

Application Number Title Priority Date Filing Date
ES74425936A Expired ES425936A1 (es) 1973-05-03 1974-05-03 Procedimiento para preparar compuestos antihistaminicos.

Country Status (18)

Country Link
US (1) US3932644A (2)
JP (1) JPS5855145B2 (2)
AU (1) AU477220B2 (2)
BE (1) BE814032A (2)
CA (1) CA1041108A (2)
CH (1) CH605917A5 (2)
DE (1) DE2421548A1 (2)
ES (1) ES425936A1 (2)
FI (1) FI62301C (2)
FR (1) FR2227869B1 (2)
GB (1) GB1419994A (2)
HU (1) HU168863B (2)
IE (1) IE40014B1 (2)
IL (1) IL44526A (2)
IN (1) IN138721B (2)
NL (1) NL7404811A (2)
SE (1) SE416299B (2)
SU (1) SU719500A3 (2)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578459A (en) * 1973-05-03 1986-03-25 Smithkline & French Laboratories Limited Heterocyclic alkylaminoheterocycles
JPS5239976U (2) * 1975-09-12 1977-03-22
US4218452A (en) 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
IN146736B (2) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4145546A (en) 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
US4378365A (en) * 1976-05-14 1983-03-29 Smith Kline & French Laboratories Limited Pharmaceutical compositions
US4649138A (en) * 1976-05-14 1987-03-10 Smithkline & French Laboratories Limited Pharmaceutical compositions
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IN151188B (2) * 1978-02-13 1983-03-05 Smith Kline French Lab
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
AR228941A1 (es) 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
DE2963363D1 (en) 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4584384A (en) * 1978-05-30 1986-04-22 Smith Kline & French Laboratories Limited Nitro pyrroles
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
EP0014057B1 (en) 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4256743A (en) * 1979-02-22 1981-03-17 President And Fellows Of Harvard College Inhibition of bone resorption with H1 -blocking antihistamines
ZA801151B (en) * 1979-03-02 1981-02-25 Glaxo Group Ltd Heterocyclic derivatives
JPS55120571A (en) * 1979-03-02 1980-09-17 Glaxo Group Ltd Heterocyclic derivative
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
DE3067564D1 (en) * 1979-10-22 1984-05-24 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL61233A (en) * 1979-10-24 1984-08-31 Smith Kline French Lab Guanidino thiazolylalkylamino(alkylthioalkylamino)nitro pyrroles,process for their preparation and pharmaceutical compositions containing them
IL61234A (en) * 1979-10-24 1984-03-30 Smith Kline French Lab Guanidino thiazolyl alkylamino(alkylthioalkylamino)nitrotetrahydropyridines,process for preparing them and pharmaceutical compositions containing them
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4439609A (en) * 1980-10-01 1984-03-27 Smith Kline & French Laboratories Limited Pyridines
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4439437A (en) * 1981-04-28 1984-03-27 Smith Kline & French Laboratories Limited 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
US4525477A (en) * 1981-12-02 1985-06-25 Smith Kline & French Laboratories Limited 2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds
GR79384B (2) * 1982-08-20 1984-10-22 Hoechst Uk Ltd
EP0104611A3 (en) * 1982-09-28 1985-06-12 Hoechst Uk Limited Thiatriazine derivatives
JO1275B1 (en) * 1982-12-03 1985-04-20 هنري براون ثوماس Chemical process
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
JO1279B1 (en) * 1982-12-23 1985-04-20 جون ايف روبرت Pyridine derivatives
DE3375574D1 (en) * 1982-12-23 1988-03-10 Smith Kline French Lab Pyridine derivatives
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB9715814D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H3 receptor ligands
GB2344588B (en) * 1997-07-25 2001-11-14 Black James Foundation 1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758759A (fr) * 1969-11-12 1971-05-10 Merck & Co Inc Pyridones anti-inflammatoires
US3853897A (en) * 1971-07-16 1974-12-10 Merck & Co Inc Certain 1-substituted-3-amino-1(2h)pyridones

Also Published As

Publication number Publication date
AU477220B2 (en) 1976-10-21
DE2421548A1 (de) 1974-11-21
BE814032A (fr) 1974-10-22
FI62301C (fi) 1982-12-10
JPS5855145B2 (ja) 1983-12-08
FR2227869B1 (2) 1978-07-21
IE40014L (en) 1974-11-03
CA1041108A (en) 1978-10-24
AU6859874A (en) 1975-11-06
NL7404811A (2) 1974-11-05
FR2227869A1 (2) 1974-11-29
JPS5025565A (2) 1975-03-18
SE416299B (sv) 1980-12-15
FI62301B (fi) 1982-08-31
IN138721B (2) 1976-03-20
CH605917A5 (2) 1978-10-13
US3932644A (en) 1976-01-13
IL44526A0 (en) 1974-06-30
IE40014B1 (en) 1979-02-28
GB1419994A (en) 1976-01-07
SU719500A3 (ru) 1980-02-29
IL44526A (en) 1979-05-31
HU168863B (2) 1976-07-28

Similar Documents

Publication Publication Date Title
ES425936A1 (es) Procedimiento para preparar compuestos antihistaminicos.
ES426405A1 (es) Procedimiento para la produccion de derivados de 1,1-diami-noetileno.
ES475240A1 (es) Un procedimiento de compuestos polienicos.
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
SE422685B (sv) Forfarande for framstellning av 2-(4-(tetrahydro-2-furoyl)-piperazin)-4-amino-6,7-dimetoxikinazolin
RO71011A (ro) Catalizator pentru conversia compusilor organici
DK389480A (da) Derivater af 6beta-hydroxyalkyl-penicillansyrer til anvendelse som beta-lactamse-inhibitorer
DK139979C (da) Fremgangsmaade til fremstilling af inhibitorer for glycosidhydrolaser
IT1006282B (it) Traduttore di ricezione per siste ma cosiddetto pcm
IT982838B (it) Composto eterociclico d azoto per composizioni fluide idrocar buriche
IT1063938B (it) Strati di barriera verso inibitori,per materiali fotografici
IT1066264B (it) Recupero di glicoli di etilene
AR211860A1 (es) Procedimiento para la elaboracion de nuevos derivados de la 4-(2-benzofuranil)-piperidina
SE7707129L (sv) Dipeptider
DK160313C (da) 7-aminocephalosporinderivater til anvendelse som mellemprodukt til fremstilling af cephalosporinderivater
CU34216A (es) Derivados de dibenzofurano
DK136469B (da) Analogifremgangsmåde til fremstilling af 2-(phenoxyalkylthio)-imidazolderivater.
NO740730L (no) Verktøy for mekanisk istykkerdeling av stein.
DK331976A (da) Fremgangsmade til fremstilling af 4-(hydroxymethyl)imidazolforbindelser
FI801053A7 (fi) Heterosyklisiä yhdisteitä.
IT1023142B (it) Mono e.o di alchilfosfati come aggiunte per leganti idraulici
ES412101A1 (es) Procedimiento para preparar derivados de n,n'-difenil-n- (n'-alquicarbamoil) formamidina.
IT1065970B (it) Procedimento per la fabbricazione di composti eterociclici
AR208302A1 (es) Un procedimiento para preparar nuevos derivados del 2-(n-(aminoalquil)-fenilaminometil)-1,3-benzodioxol
DK567576A (da) Cyclopentenderivater til brug som mellemprodukter til fremstilling af prostaglandiner